|Articles|November 1, 2013
- Applied Clinical Trials-11-01-2013
- Volume 22
- Issue 11
Applied Clinical Trials Digital Edition - November 2013
Regulatory: Successful Phase III Trial Monitoring Trial Design: Multi-regional Trials Data Evaluation Also in this issue: Compromise in Europe's Rule Debate True Potential of Adaptive Trial Designs Bring Your Own Device
Advertisement
Articles in this issue
over 12 years ago
Sponsors Struggle with Data Disclosure Requirementsover 12 years ago
Evaluation of Data for Multi-Regional Trials: A Three-Layer Approachover 12 years ago
Cost Per Visit Trends Higher for Less Established Regionsover 12 years ago
Modeling Successful Phase III Trialsover 12 years ago
GCP's Future: Looking Ahead to the Next 20 Yearsover 12 years ago
Crunch-Time for Europe's Clinical Trials Rulesover 12 years ago
Device Independence is the Future of Clinical Trialsover 12 years ago
Business and People November 2013over 12 years ago
Adoption of Adaptive Trial Designs Poised to AccelerateAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
2
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
3
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
4
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
5